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Background: The association between hyperuricemia, hypertension, and diabetes has been proved to have strong
association with the risk for cardiovascular diseases, but it is not clear whether hyperuricemia is related to the early
stages of hypertension and diabetes. Therefore, in this study we investigated the association between
hyperuricemia, prediabetes, and prehypertension in Croatian adults, as well as that between purine-rich diet and
hyperuricemia, prediabetes, or prehypertension.
Methods: A stratified random representative sample of 64 general practitioners (GP) was selected. Each GP
systematically chose participants aged ≥ 40 year (up to 55 subjects) . Recruitment occurred between May and
September 2008. The medical history, anthropometric, and laboratory measures were obtained for each participant.
Results: 59 physicians agreed to participate and recruited 2485 subjects (response rate 77%; average age
(± standard deviation) 59.2 ±10.6; 61.9% women. In bivariate analysis we found a positive association between
hyperuricemia and prediabetes (OR 1.66, 95% CI 1.09–2.53), but not for prehypertension (OR 1.68, 95% CI 0.76–3.72).
After controlling for known confounders for cardiovascular disease (age, gender, body mass index, alcohol intake,
diet, physical activity, waist to hip ratio, total cholesterol, low density lipoprotein, high density lipoprotein, and
triglycerides), in multivariate analysis HU ceased to be an independent predictor(OR 1.33, CI 0.98–1.82, p = 0.069) for
PreDM. An association between purine-rich food and hyperuricemia was found (p<0.001) and also for
prediabetes (p=0.002), but not for prehypertension (p=0.41). The prevalence of hyperuricemia was 10.7%
(15.4% male, 7.8% female), 32.5% for prediabetes (35.4% male, 30.8% female), and 26.6% for prehypertension
(27.2% male, 26.2% female).
Conclusion: Hyperuricemia seems to be associated with prediabetes but not with prehypertension. Both,
hyperuricemia and prediabetes were associated with purine-rich food and patients need to be advised on
appropriate diet.
Trial registration: Current Controlled Trials ISRCTN31857696
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A large number of studies have linked hyperuricemia
(HU) with hypertension, cardiovascular disease, and dia-
betes [1,2]. An association was shown between elevated
concentrations of serum uric acid (SUA) and increased
mortality in patients with myocardial infarction, heart
failure, stroke, and other diseases [3,4] and also with a
purine-rich diet, alcohol intake, and a number of cardio-
vascular disease (CVD) risk factors [5].
Experimental models have demonstrated that an elevated
concentration of serum uric acid (SUA) increases blood
pressure without affecting the morphology of the kidney
[6], and that lowering uric acid can normalize blood pres-
sure [7]. In addition to the association between SUA and
hypertension, many authors have confirmed the correlation
between SUA and development of type 2 diabetes [8]. The
results showed that every increase of serum uric acid by
59.5 μmol/L results in a 60% increase in risk for developing
diabetes [9]. Although there is unquestionable evidence of
the association between uric acid and oxidative stress,
endothelial dysfunction, inflammation, subclinical athero-
sclerosis, and cardiovascular disease there is no consensus
regarding its value as an independent risk factor [10,11].
Consequently, if hyperuricemia contributes to hyper-
tension and diabetes, the assumption is that it should
also contribute to prehypertension (PreHT) and predia-
betes (PreDM). While hyperuricemia’s relationship with
hypertension and diabetes has been well studied, few
studies dealt with the relationship between hyperurice-
mia and PreHT [12,13], and PreDM [14]. The aim of
our study is to assess whether SUA level is associated
with PreHT and/or PreDM in an adult population in a
Croatian primary care setting.Methods
Study design
The survey was conducted between May 2008 and July
2008 within a representative, random sample of general
practitioners (GP), who were enrolled by a random num-
ber generator based on a list of all registered family medi-
cine practices (2374 in total) from the Croatian Institute
for Health Insurance. Stratification of GP’s was made by
region (coastal or continental), county (Croatia is divided
into 21 counties), settlement size (up to 3999 inhabitants,
4000 to 9999, 10 000 to 29 999, 30 000 to 89 999, and 90
000 inhabitants and more), and number of insured
patients based on a list of all GP’s/family medicine prac-
tices having a contract with the Croatian Institute for
Health Insurance (national compulsory health insurance
system covering 97% of the population) in 2007.
Taking into consideration the available data for the preva-
lence of risk factors for cardiovascular diseases in Croatia,
and the expected dispersion of examined persons (20%), wedetermined that each GP should examine 55 patients (80%
power, alpha 0.05, G*Power for Windows 3.1.3).
The research was carried out within the randomised
clinical trial Cardiovascular Risk and Intervention Study
in Croatia-family medicine (CRISIC- fm), and was regis-
tered as a clinical trial (Current Controlled Trials -
ISRCTN31857696).
The study was approved by the Ethics Committee of
Zagreb University School of medicine.
Participants
Each general practitioner (GP) enrolled a consecutive,
representative sample of participants aged ≥ 40 years (up
to 55 subjects), who visited the practice from May 2008
to July 2008 who meet the criteria and provided
informed consent to participate. The exclusion criteria
included communication disability (dysphasia, aphasia),
severe dementia or mental illness, and disease with an
estimated life expectancy of less than six months.
All GP received precise instruction to enrol two
patients per day between 10 am and 11am during their
morning shift, and between 4 pm and 5 pm during their
afternoon shift.
The interviews and two questionnaires that contained
140 and 127 items, respectively, were used to collect the
socio-demographic, socio-economic, personal and family
history data, and also information on the dietary and li-
ving habits, physical activity, medical therapy, psycho-
logical aspects and environment of the participants. The
first questionnaire was administered and the anthropo-
metric measurements were taken on the first day by the
GP and the second questionnaire was given to patients
to complete at home and return the following week
when they arrive at the surgery for blood sampling after
a minimum 8-hour fast.
Measurement
All subjects were measured twice for height and weight
(using identical standardised anthropometric scales),
waist and hip circumference (by plastic coated, non-
elastic centimetre tape), blood pressure (by mercury
sphygmomanometer), and pulse rate. Data on smoking
were obtained by self-assessment (smokers, former smo-
kers who stopped smoking > 6 months, and nonsmo-
kers). Moderate drinking was defined as 20 g ethanol
per day for men and 10 g for women and the data were
obtained by self-assessment. Overweight was defined as
BMI ≥ 25 and obesity as BMI ≥ 30. Hypertension was
defined as ≥ 140 systolic and/or ≥ 90 diastolic, or the
use of antihypertensive drugs [15]. Diabetes mellitus was
defined as fasting plasma glucose ≥ 7.0 mmol/L, or the
use of hypoglycaemic drugs. Serum uric acid (SUA), fast-
ing blood glucose (FBG), total cholesterol (TC), high
density lipoprotein cholesterol (HDL), low density
Table 2 Basic characteristics of the study population
Characteristic Total




Total cholesterol (TC) mmol/L 5.8±1.2
Low density lipoprotein cholesterol (LDL-C) mmol/L 3.5±1.08
High density lipoprotein cholesterol (HDL-C) mmol/L 1.5±0.4
Fasting blood glucose (FBG) mmol/L 6.0±2.3
Triglyceride (TG) mmol/L 1.9±1.4
Systolic blood pressure (SBP) mmHg 131.4±17.0
Diastolic blood pressure (DBP) mmHg 80.7±9.2
Serum uric acid (SUA) μmol/L 287.7±99.5
Smoking, n (%) 539 (22.4%)
Physically active, n (%) 1254 (56.0%)
Hyperuricemia, n (%) 240 (10.7%)
Prehypertension (PreHT), n (%) 595 (26.6%)
Prediabetes(PreDM), n (%) 729 (32.5%)
Alopurinol use, n (%) 64 (2.9%)
Smoking – actual smoking or less than 6 months since quitting.
Physically active – at least 150 min/week moderate to vigorous physical activity.
Hyperuricemia (≥ 420 μmol/L men, ≥ 360 μmol/L women).
Prehypertension PreHT (SBP 120–139 mmHg and/or DBP 80–89 mmHg).
Prediabetes PreDM (fasting blood glucose 5.6–6.9 mmol/L).
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tinine, complete blood count, and complete urine ana-
lysis were performed. Hyperuricemia (HU) was defined
as serum uric acid concentration ≥ 420 μmol/L in men
and ≥ 360 μmol/L in women. PreHT was determined
using JNC7 [16] definition, and considered to be blood
pressure readings based on the average of 2 or more
properly measured, seated BP readings on each of 2 or
more office visits with a systolic pressure from 120 to
139 mm Hg or a diastolic pressure from 80 to 89 mm
Hg. PreDM was determined using the criteria from the
American Diabetes Association [17] with fasting plasma
glucose level from 5.6 mmol/L to 6.9 mmol/L.
For dietary habits, the subjects were divided into 4
groups according to the frequency of purine-rich food
consumption [18]. The first group comprised of subjects
with a total of 0–5 points, the second 6–10 points, the
third 11–15 points, and the fourth 16–20 points. The
scoring is shown in Table 1.
Statistical analysis
The basic characteristics of the sample were described by
descriptive statistics. The differences between the catego-
rical variables with relative risk for PreDM and PreHT
were analyzed using the chi-square test. Logistic regres-
sion analysis was used to examine which variables were
statistically significant risk factors in certain groups in re-
lation to and adjusted for the relevant confounders using
bivariate analysis. All values were interpreted according to
a significance level of 95% (CI 95%, P < 0.05). All statistical
methods were performed using SPSS for Windows
(19.0.0.1, SPSS Inc., Chicago, Illinois, 2011).
Results
Fifty-nine physicians recruited a total of 2485 subjects
(response rate 77%). There were 61.9% women (mean
age (± standard deviation) 58.9 ± 10.5) and 38.1% men
(mean age 59.5 ± 10.7). Their basic characteristics are
shown in Table 2.
Hyperuricemia prevalence in the observed population
was 10.7% (240) (men 15.4%, women 7.8%), and was
more frequent in men (χ 2 = 33.6, p < 0.001). AlthoughTable 1 Scoring of purine-reach food consumption
Everyday Few times a wee
but not everyda
Red meat and red meat products 4 3
Wine and/or beer 4 3
Liquor 4 3
Sugar sweetened soft drinks (fructose) 4 3
Animal fat 4 3
Totalthe prevalence of hyperuricemia was equal in men and
women over 60 years of age, treatment with allopurinol
was more frequent in men (χ 2 = 28.1, p<0.001).
The prevalence of PreHT was 26.6% (595) (men 27.2%,
women 26.2) and of PreDM was 32.5% (729) (men
35.4%, women 30.8%).
The average values of SUA in men who had PreHT
and PreDM did not differ relative to normotensive/non-
diabetic man (t = 1.67, p = 0.097). In contrast, women
with PreHT/PreDM have higher averaged values of SUA
(t = 3.37, p = 0.001).
Bivariate analysis showed that hyperuricemia was sig-
nificantly associated with PreDM (OR 1.71, CI 1.29–
2.28, p < 0.001) but not with PreHT in men (OR 1.75,k
y








Table 3 Odds ratio of PreDM and PreHT based on clinical variables
Variables Prediabetes Prehypertension
OR 95% CI p OR 95% CI p
Female gender 0.71 0.6–0.9 <0.001 0.79 0.63–1.03 0.059
Age ≥ 60 yrs 1.17 0.99–1.40 0.067 1.14 0.90–1.45 0.273
Smoking 0.72 0.57–0.90 0.005 0.65 0.50–0.85 0.002
Hyperuricemia (≥420 m i ≥360 f) 1.71 1.29–2.28 <0.001 1.34 0.87–2.14 0.180
BMI overweight (25–29.9 kg/m2) 1.41 1.11–1.79 0.005 1.38 1.05–1.80 0.020
BMI obese (≥30 kg/m2) 2.01 1.58–2.57 <0.001 1.34 0.99–1.79 0.060
Waist-to-hip ratio (WHR) 1.44 1.19–1.74 <0.001 1.16 0.91–1.47 0.245
Pro-uric diet (score >10) 1.61 1.25–2.06 <0.001 1.17 0.84–1.64 0.393
Alcohol consumption 1.3 1.06–1.58 <0.001 0.97 0.75–1.24 0.848
Triglycerides (>1.7mmol/L) 1.47 1.23–1.75 <0.001 1.27 1.01–1.60 0.045
Total cholesterol (>5.0 mmol/L) 1.09 0.86–1.30 0.560 0.87 0.67–1.14 0.365
HDL-cholesterol (m <1.03, f <1.29 mmol/L) 1.24 0.99–1.56 0.069 0.88 0.65–1.21 0.440
LDL-cholesterol (>3.0 mmol/L) 1.03 0.83–1.27 0.829 0.84 0.63–1.11 0.250
Smoking – actual smoking or less then 6months since quitting.
Waist-to-hip ratio – m >0.9, f >0.85.
Pro-uric diet – according to Table 1.
Alcohol consumption – > 20g ethanol per day for men and > 10g for women.
Vučak et al. BMC Cardiovascular Disorders 2012, 12:117 Page 4 of 6
http://www.biomedcentral.com/1471-2261/12/117CI 0.70–2.39, p = 0.23) and women (OR 1.75, CI 0.66–
2.62, p = 0.262). Only BMI was a predictor for PreHT.
The data are shown in Table 3. All significant bivariate
findings were used in multivariate logistic regression
models for PreDM and PreHT. After controlling for the
impact of significant risk factors (gender, BMI status, al-
cohol intake, diet, smoking, and triglycerides) HU ceased
to be a significant independent predictor (OR 1.33, CI
0.98–1.82, p = 0.069) for PreDM . For the PreHT group,
only non-smoking habit was a significant predictor when
controlled for BMI status, smoking, and triglycerides
(OR 1.52, CI 1.16–1.99, p = 0.03).
Participants with a higher pro-uric food intake were
obese (χ2 = 14.01, p = 0.007) and had higher uric acid
values (χ2 = 10.29, p = 0.006). Participants with PreHT do
not show significant differences in the frequency of pro-
uric food intake, while participants with PreDM consume
pro-uric food more often as it shown in Table 4.Table 4 Relationship between purine-rich diet and HU, PreHT
Diet* N (%) HU PreHTN
N=228 N=641
N (%) N (%)
Score 0–4 873 (37.4%) 56 (24.6%) 223 (34.
Score 5–10 1156 (49.5%) 128 (56.1%) 327 (51.
Score 11–15 292 (12.5%) 43 (18.9%) 87 (13.6
Score 16–20 13 (0.6%) 1 (0.4%) 4 (0.6%)
P** <0.001 0.406
*frequency of pro-uric food intake according to Table 1.
**X2 test.Discussion
This study showed an association between hyperuricemia
and prediabetes, whereas the association with prehyper-
tension was questionable and significant only when asso-
ciated with increased BMI and triglycerides. Furthermore,
we found that BMI remained the only predictor for prehy-
pertension, while hyperuricemia was a predictor for pre-
diabetes when combined with BMI. This is compatible
with the study of Ishizaka et al. proposing a correlation
between SUA, BMI, and waist circumference [19]. The
PreCIS study [20] has shown that uric acid levels are
increased in patients with hypertension and diabetes,
while we showed that this association also exists in
patients with prediabetes, even when other risk factors for
cardiovascular disease are excluded.
There are a number of studies associating oxidative
stress with the development of diabetes mellitus and its
complications [21]. Since SUA is one of the most powerful, PreDM, and BMI
PreDM BMI(25–29.9) BMI(>30)
N=771 N=994 N=834
N (%) N (%) N (%)
8%) 255 (33.1%) 373 (37.5%) 284 (34.1%)
0%) 382 (49.5%) 490 (49.3%) 428 (51.3%)
%) 127 (16.5%) 126 (12.7%) 116 (13.9%)
7 (0.9%) 5 (0.9%) 6 (0.7%)
0.002 0.200 0.009
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lial cells, there are speculations that high concentrations
of SUA are the result of the body defensive mechanisms.
On the other hand, norepinephrine infusions and/or
angiotensin II lead to reversibly elevated blood pressure
and SUA. In this context, a possible mechanism could be
an increase in sympathetic activity leading to oxidative
stress, and the body’s effort to reduce damage using its
most powerful antioxidant and to the breakdown of com-
pensatory mechanisms. This is supported by studies that
associated increases in norepinephrine level, blood pres-
sure, and SUA with increased body mass and further
hypertension progression [22].
It is known that uric acid clearance is inversely corre-
lated with insulin resistance, which is the main patho-
physiological factor of all metabolic syndrome (MS)
components. There is some level of agreement that uric
acid levels should be determined in MS patients because
of the association with major cardiovascular risk, espe-
cially in woman [23]. This study shows that other com-
ponents of metabolic syndrome (BMI, TG, and WHR)
also play a significant role in prediabetes incidence in
the presence of HU. Accordingly, the measurement of
SUA should be introduced as an additional indicator of
poor prognosis in patients with metabolic syndrome,
which is in accordance with recent studies [24,25].
We found that HU prevalence in Croatian adults was
10.7% (15.4% male, 7.8% female) and was lower than in
other populations. This may be because the population
only included subject of Caucasian origin. The lack of a
relationship between hyperuricemia and prehypertension
may be partly explained by the lower prevalence of hyper-
uricemia in the studied population than in other popula-
tions, where it ranges from 21.3% to 26.2% [26-28].
Sundström et al. [29] confirmed the independent effect
of elevated uric acid levels on hypertension incidence
and on its progression. Therefore a higher incidence of
hyperuricemia is to be expected in prehypertensive
patients, but our study did not show this. This implies
that the progression from prehypertension to hyperten-
sion occurs through other mechanisms favored by the
increased SUA or occurred in parallel with the increase,
but is not caused by it. This conclusion is consistent
with findings from a previous study by the same authors,
who followed a subgroup for 12 years and observed the
connection between uric acid levels and hypertension
incidence disappeared. It is also in concordance with
findings that allopurinol administration improves endo-
thelial function but has no significant effect on systemic
blood pressure in patients with type II diabetes and mild
hypertension [30].
The prevalence of HU in women and men was similar
in older age groups. Fang et al. found a strong relationship
between increased UA and cardiovascular mortalityamong women [11], even after adjusting for diuretic use
and menopausal status. Considering this fact, which was
also demonstrated by our study, the relationship between
HU and prehypertension is especially strong in postmeno-
pausal women probably because they lose the uricosuric
effect of estrogen. This may contribute to the increased
risk of adverse cardiovascular events.
To the best of our knowledge, most previous studies
have not been taken into account eating habits even
though they could affect UA levels. We therefore sought
to investigate further and divide the patients into 4
groups according to their dietary habits (consumption of
purine rich-food). The obtained results continued to cor-
relate HU with prehypertension and prediabetes in spite
of differences in dietary habits.
Strength and limitations of the study
Strength: The large community based sample and ad-
justment for numerous potential confounders, including
eating habits, of the studied population strengthen our
investigation.
Limitations: It was a cross-sectional study and so the
causal relationship between serum uric acid concentra-
tion with prediabetes and prehypertension cannot be
evaluated.
Conclusion
Since prehypertension and prediabetes are pre-stages of
hypertension and diabetes, respectively, it can be
expected that HU will be more often present in persons
suffering from prehypertension and/or prediabetes. We
have proved that this is the case only with prediabetes
and not with prehypertension. Purine-rich food is related
with both, HU and prediabetes, and patients need to be
advised on appropriate diet.
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